H Lundbeck A/SEigentümerstruktur
| Preis (2026-07-24) | 52W Hoch | 52W Tief |
| 42.12 DKK | 46,334 DKK | 32,234 DKK |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| - DKK | - | - | - | - | - |
| #Shares | Short [%] | Short Ratio |
| 793.128.424 | - | - |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name H Lundbeck A/S
Mitarbeiter 5.000
Handelsplatz CO
Ticker Symbol HLUN-B
IPO Datum -
Adresse Ottiliavej 9, Valby, Denmark, 2500
Webseite https://www.lundbeck.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Charl van Zyl | President & CEO |
| 2 | Mr. Joerg Hornstein | CFO & Executive VP of Corporate Functions |
| 3 | Mr. Lars Bang | Executive Vice President of Product Development & Supply |
| 4 | Dr. Per Johan Luthman Ph.D. | Executive Vice President of Research & Development |
| 5 | Dr. Tarek Samad Ph.D. | Senior VP & Head of Research |
| 6 | Jens Hoyer | Vice President & Head of Investor Relations |
| 7 | Ms. Tine Ostergaard Hansen | Senior Vice President of Corporate Communications & Public Affairs |
| 8 | Ms. Dianne Holto | Executive Vice President of People, Culture & Sustainability |
| 9 | Mr. Thomas E. Gibbs | Executive VP & Head of Lundbeck in United States |
| 10 | Prof. Johannes Rolf Streffer M.D. | Senior VP & Head of Global Clinical Development |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
Für dieses Unternehmen liegen derzeit keine Daten zu institutionellen Investoren vor.